Articles & courses

ArticlesShow all 368
A New Approach to Acute Coronary Syndromes: Occlusion MI (OMI) vs. Non-Occlusion MI (NOMI)

…and clinical experience. Studies have demonstrated that a significant proportion of patients with acute coronary occlusion (ACO) do not exhibit classic ST segment elevation on…

Ventricular Tachycardia

…and landmark clinical trials, the field has transitioned from a predominantly pharmacological strategy to one that heavily integrates early catheter ablation and sophisticated device therapy…

Blood Pressure Targets in Older and Frail Adults

…and functional deterioration may have greater consequences in frail patients. Clinical Assessment Frailty and Functional Status Treatment decisions should not be based on age alone…

🟠 ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Bleeding Risk Score

…in Atrial Fibrillation) Bleeding Risk Score is a clinical tool designed to estimate the risk of major bleeding in patients with atrial fibrillation (AF) undergoing…

Ivabradine: Indications, Dosing and Heart-Rate Targets

…the trial based threshold: ivabradine was approved for patients with HFrEF, LVEF <35%, sinus rhythm and resting heart rate 75 beats/min, based on a…

Extracorporeal cardiopulmonary resuscitation (ECPR)

…2023) : In a multicenter, randomized trial, the effects of extracorporeal cardiopulmonary resuscitation (ECPR) was compared to conventional CPR in patients with refractory out of hospital…

Complete Versus Culprit-Only Revascularization in Acute Coronary Syndrome

…important therapeutic objective, particularly in patients with left ventricular dysfunction and/or MVD. Nevertheless, the optimal extent and timing of intervention depend on the clinical…

Complications of Coronary Angiography and Vascular Access Management

…in the general sense; the decision depends on balancing the expected diagnostic or therapeutic benefit against the patient’s specific procedural risks. Vascular access and…

ACE Inhibitor Cough and Angioedema: Practical Management

…cough hypersensitivity syndrome are lacking; the diagnosis is suspected when alternative etiologies are excluded by diagnostic testing or failed therapeutic trials. If alternative causes of…

Inclisiran and Emerging Lipid-Lowering Agents

…Effects on triglycerides and lipoprotein(a) are variable or modest. In phase III studies involving patients with ASCVD or at least one ASCVD risk equivalent…

Media

No matches.

Tools